Akorn Hid Delays Integrating VersaPharm, Shareholder Says
Akorn Inc. failed to disclose it was lagging in integrating VersaPharm Inc. and another newly acquired subsidiary into its accounting system, artificially inflating the market price of its securities, an Akorn...To view the full article, register now.
Already a subscriber? Click here to view full article